Rubella virus total antibody IVD, kit, rapid agglutination, clinical

This category includes diagnostic test kits designed to detect total antibodies against the rubella virus in clinical specimens such as blood or serum. These kits use a rapid agglutination method to provide qualitative or semi-quantitative results quickly, supporting timely assessment of rubella immunity or recent infection in clinical or laboratory settings.

Devices in this category are intended for use by trained healthcare professionals in laboratory or point-of-care environments and are not suitable for self-testing. They are regulated as in vitro diagnostic medical devices and supplied as complete reagent kits containing all necessary components for performing the test, with performance characteristics established through validation rather than implying any specific regulatory classification.